Biogen CEO: ‘Major bottleneck’ still limits Alzheimer’s drug
A new Alzheimer’s drug from Biogen brought in only $300,000 in sales during its first full quarter on the market,
Read moreA new Alzheimer’s drug from Biogen brought in only $300,000 in sales during its first full quarter on the market,
Read moreDirect-acting oral anticoagulants such as apixaban are the most widely used medications of this type in people with atrial fibrillation,
Read moreSACRAMENTO, Calif. — The board that licenses and disciplines doctors in California is failing to hold bad actors accountable, endangering
Read morePfizer now testing COVID-19 vaccine on children ages 5-11 Fox News medical contributor Dr. Janette Nesheiwat discusses Pfizer’s tests and
Read moreThe so-called Plexin-A1 gene seems to play a more extensive role in brain development than previously assumed. This is shown
Read moreWhile there was extensive use of drug repurposing throughout the first 10 months of the COVID-19 pandemic, there was substantial
Read moreHow much do you bench? It’s one of those regular questions among gym-bros, something you’re almost guaranteed to get asked
Read moreDiphtheria—a relatively easily-preventable infection—is evolving to become resistant to a number of classes of antibiotics and in future could lead
Read moreWashington University School of Medicine in St. Louis is part of a national research network aiming to discover rare forms
Read moreFRIDAY, Nov. 20, 2020 — For patients with primary central nervous system lymphoma (PCNSL), the incidence of venous thromboembolism (VTE)
Read more